Skip to content
Bored Studies
Recruiting

Post-Approval Study of the Neuspera Sacral Neuromodulation System

Neuspera Medical, Inc. · NCT07144813

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 22+ · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Not applicable
Target enrollment
116
US sites recruiting
1
Study start
September 3, 2025
Record last updated
February 4, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Prospective, multi-center, single-arm, post-approval study is designed to assess the long-term safety and efficacy data of the Neuspera Sacral Neuromodulation (SNM) System following commercial approval of the Neuspera SNM System.

Participants in this study received intervention/implanted in Phase I or Phase II of the Neuspera SANS_UUI (NSM-004) Study.

Being studied: Neuspera Implantable Sacral Neuromodulation System

Conditions: Urinary Urgency Incontinence

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Subjects in the SANS-UUI Phase I or Phase II study

Exclusion Criteria

  • None

Recruiting US locations

  • Urology Austin,

    Austin, TX 78759

    Site contact: Brian Mazzarella, MD · (502)-569-7904

Study contacts (from the official record)

  • Mark Vollmer · 408-433-3839 · mark.vollmer@neuspera.com
  • Shital Patel · 323-528-1320 · shital.patel@neuspera.com
Post-Approval Study of the Neuspera Sacral Neuromodulation System (NCT07144813) | Bored Studies